Jacobs Levy Equity Management Portfolio holdings
Jacobs Levy Equity Management manages U.S. stock portfolios, and its owners Bruce Jacobs and Ken Levy pioneered a research method called disentangling. The firm was founded in 1986, and Jacobs and Levy spent more than three years studying market inefficiencies in U.S. stocks before taking on client money in 1990. Disentangling examines many factors that move stock prices at once, to isolate the separate effect of each, and the firm blends it with behavioral finance theory and human judgment. It runs long-only and long/short portfolios across large and small companies, including versions that hold about 130% or 150% of capital in long positions and 30% or 50% in short ones. Its clients are institutions such as pension plans, endowments, foundations and sovereign wealth funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$325M |
| 2 |
CrowdStrike
CRWD
|
+$225M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$186M |
| 4 |
Sandisk
SNDK
|
+$155M |
| 5 |
Sysco
SYY
|
+$147M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$418M |
| 2 |
ServiceNow
NOW
|
+$262M |
| 3 |
Apple
AAPL
|
+$260M |
| 4 |
Masco
MAS
|
+$163M |
| 5 |
Roku
ROKU
|
+$139M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.14% |
| 2 | Financials | 13.01% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Industrials | 11.2% |
| 5 | Healthcare | 10.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
701
Phibro Animal Health
PAHC
$1.46B
| $1.04M | ﹤0.01% |
33,024
-80,994
| -71% | -$3.42M |
2023 Q4
10 quarters
|
|
702
Safety Insurance
SAFT
$1.53B
| $1.04M | ﹤0.01% |
+13,849
| New | +$1.01M |
2026 Q2
0 quarters
|
|
703
Frontier Group Holdings
ULCC
$1.75B
| $1.04M | ﹤0.01% |
+131,060
| New | +$676K |
2026 Q2
0 quarters
|
|
704
Niagen Bioscience
NAGE
$163M
| $1.04M | ﹤0.01% |
+324,690
| New | +$1.32M |
2026 Q2
0 quarters
|
|
705
TScan Therapeutics
TCRX
$10.9M
| $1.03M | ﹤0.01% |
1,049,806
+241,450
| +30% | +$257K |
2025 Q4
2 quarters
|
|
706
Radiant Logistics
RLGT
$439M
| $1.02M | ﹤0.01% |
107,688
-9,451
| -8% | -$79.6K |
2017 Q1
37 quarters
|
|
707
Atlanticus Holdings
ATLC
$1.28B
| $1.01M | ﹤0.01% |
9,881
-11,031
| -53% | -$895K |
2025 Q1
5 quarters
|
|
708
Nektar Therapeutics
NKTR
$1.27B
| $1.01M | ﹤0.01% |
14,435
-15,706
| -52% | -$1.15M |
2022 Q2
16 quarters
|
|
709
C3.ai
AI
$1.9B
| $998K | ﹤0.01% |
109,758
-172,086
| -61% | -$1.63M |
2025 Q4
2 quarters
|
|
710
WaFd
WAFD
$2.18B
| $984K | ﹤0.01% |
25,643
-5,886
| -19% | -$207K |
2025 Q2
4 quarters
|
|
711
GeneDx Holdings
WGS
$1.57B
| $980K | ﹤0.01% |
14,281
-663
| -4% | -$37.7K |
2025 Q1
5 quarters
|
|
712
Jakks Pacific
JAKK
$414M
| $978K | ﹤0.01% |
41,996
-2,776
| -6% | -$61.5K |
2025 Q1
5 quarters
|
|
713
Magnolia Oil & Gas
MGY
$6.54B
| $972K | ﹤0.01% |
37,985
-1,301
| -3% | -$37.2K |
2024 Q1
9 quarters
|
|
714
CeriBell Inc
CBLL
$1.02B
| $972K | ﹤0.01% |
49,951
+6,995
| +16% | +$133K |
2026 Q1
1 quarter
|
|
715
Core Molding Technologies
CMT
$190M
| $970K | ﹤0.01% |
41,081
-3,057
| -7% | -$75.2K |
2023 Q3
11 quarters
|
|
716
Zymeworks
ZYME
$1.85B
| $965K | ﹤0.01% |
36,922
-5,864
| -14% | -$149K |
2026 Q1
1 quarter
|
|
717
Resources Connection
RGP
$92.7M
| $957K | ﹤0.01% |
225,252
-339,017
| -60% | -$1.42M |
2020 Q2
24 quarters
|
|
718
BayCom
BCML
$339M
| $956K | ﹤0.01% |
29,045
+22,114
| +319% | +$677K |
2026 Q1
1 quarter
|
|
719
Adient
ADNT
$1.2B
| $950K | ﹤0.01% |
+51,685
| New | +$1.1M |
2026 Q2
0 quarters
|
|
720
Braemar Hotels & Resorts
BHR
$119M
| $941K | ﹤0.01% |
435,820
+43,003
| +11% | +$103K |
2025 Q3
3 quarters
|
|
721
HEICO Corp
HEI
$47.5B
| $936K | ﹤0.01% |
2,628
| – | – |
2025 Q2
4 quarters
|
|
722
Travelzoo
TZOO
$52.5M
| $923K | ﹤0.01% |
79,026
+27,244
| +53% | +$250K |
2025 Q1
5 quarters
|
|
723
Cactus
WHD
$5.03B
| $922K | ﹤0.01% |
17,997
-4,414
| -20% | -$246K |
2025 Q1
5 quarters
|
|
724
Datadog
DDOG
$66.5B
| $921K | ﹤0.01% |
+3,538
| New | +$658K |
2026 Q2
0 quarters
|
|
725
Teradata
TDC
$3.18B
| $917K | ﹤0.01% |
26,452
-295,496
| -92% | -$8.99M |
2023 Q3
11 quarters
|
|
Similar funds
Jacobs Levy Equity Management's Q2 2026 Portfolio in Review
As of Q2 2026, Jacobs Levy Equity Management held 1,111 positions worth $27.8B, up 17% from $23.8B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jacobs Levy Equity Management's Q2 2026 filing shows 158 new, 319 increased, 438 reduced and 177 closed positions. Its largest new stake was Sysco: 1,938,184 shares worth $162M. The largest sale was Qualcomm, an estimated $418M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2026 buy was Sysco: 1,938,184 shares worth $162M.
- Jacobs Levy Equity Management added most to KLA in Q2 2026, an estimated $325M increase.
- Jacobs Levy Equity Management's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $418M.
- Jacobs Levy Equity Management fully exited Roku in Q2 2026, selling an estimated $139M.
- Jacobs Levy Equity Management's ten largest holdings make up 28% of its $27.8B portfolio in Q2 2026.
- Jacobs Levy Equity Management opened 158 new positions and closed 177 in Q2 2026.
- Jacobs Levy Equity Management's portfolio value rose 17% quarter-over-quarter to $27.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.